[go: up one dir, main page]

JP2004243048A - Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction - Google Patents

Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction Download PDF

Info

Publication number
JP2004243048A
JP2004243048A JP2003070950A JP2003070950A JP2004243048A JP 2004243048 A JP2004243048 A JP 2004243048A JP 2003070950 A JP2003070950 A JP 2003070950A JP 2003070950 A JP2003070950 A JP 2003070950A JP 2004243048 A JP2004243048 A JP 2004243048A
Authority
JP
Japan
Prior art keywords
waveform
lymphocytes
granulocytes
sine wave
frequency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003070950A
Other languages
Japanese (ja)
Inventor
Takuji Hara
卓司 原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bestec Corp
Original Assignee
Bestec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bestec Corp filed Critical Bestec Corp
Priority to JP2003070950A priority Critical patent/JP2004243048A/en
Publication of JP2004243048A publication Critical patent/JP2004243048A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/3603Control systems
    • A61N1/36031Control systems using physiological parameters for adjustment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/3603Control systems
    • A61N1/36034Control systems specified by the stimulation parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4035Evaluating the autonomic nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36114Cardiac control, e.g. by vagal stimulation
    • A61N1/36117Cardiac control, e.g. by vagal stimulation for treating hypertension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36146Control systems specified by the stimulation parameters
    • A61N1/36167Timing, e.g. stimulation onset
    • A61N1/36171Frequency

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for controlling an electric potential treatment device, the electric potential treatment device and a method for adjusting a ratio between granulocytes and lymphocytes in a leukocyte fraction, to adjust a function of an autonomic nerve. <P>SOLUTION: An electricity with a frequency between about 30 kHz and about 50 kHz and with an electric potential between about 500 volts and about 5,000 volts is applied on the human body to flow a feeble electric current, and the ratio between granulocytes and lymphocytes in the leukocyte fraction is adjusted by changing a frequency output wave form. The electric potential which is applied by the electric potential treatment device has a function to suppress the sympathetic nerve to make the parasympathetic nerve dominant. As the result, the number of lymphocytes increases to improve blood flow and immunity is enhanced. <P>COPYRIGHT: (C)2004,JPO&NCIPI

Description

【0001】
【産業上の利用分野】
本発明は、自律神経の働きを調整するための、電位治療装置制御方法、電位治療装置及び白血球分画の顆粒球とリンパ球との比率を調整する方法及電位治療装置に関する。
【0002】
【従来の技術】
人間の血液1立方mm中に赤血球500個、白血球5000個から8000個が含まれている。また、白血球分画の54〜60%は、顆粒球であり、35〜41%はリンパ球である。そして、心配事や過労等心身のストレスがあると、自律神経、すなわち交感神経と副交感神経とのバランスが乱れやすくなり、これに連動して顆粒球とリンパ球のバランスも乱れることが知られている。
【0003】
かくして、交感神経が優位になると、顆粒球が増大し、かつ心臓の拍動が増えて血管が収縮して血圧が上がり心身は活動モードに入る。副交感神経が優位になると、リンパ球が増え、かつ心臓の拍動が抑えられて血管は拡張して血液循環が良くなり、血圧がさがってリンパ球が増えて心身は休息モードに入る。
【0004】
これら交感神経と副交感神経に連動する顆粒球とリンパ球の割合を制御する東洋医学における物理的処方として、所定のツボに針を刺して針に通電させる方法が知られている。この処方では、専門の医師がツボの位置を診て通電を行っている。従って、患者は専門の医師にその都度病院等に赴き治療をしてもらわなければならない。このため、患者にとって時間の制約や煩わしさがあった。
【0005】
【発明が解決しようとする技術課題】
本発明は、従来のこのような問題点を解決することを鑑みてなされたもので、その目的は、患者はその都度医師に診てもらう必要性がなく家庭等で簡単に自律神経を調節することができる電位治療装置制御方法、電位治療装置及び白血球分画の顆粒球とリンパ球との比率を調整する方法を提供することにある。
【0006】
【技術課題を達成するための手段】
請求項1に係る電位治療装置制御方法は、約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ周波数出力波形を正弦波交流波形、+側正弦波交流波形、−側正弦波交流波形、正弦波変調波形、正弦波変調波形に直流成分を加えた重畳波形、ゆらぎ変調波形又は矩形波波形のいずれか1つの波形で出力して白血球分画の顆粒球とリンパ球との比率を調整する。
【0007】
請求項2に係る電位治療装置制御方法は、白血球分画の顆粒球を減少してリンパ球を増やすことを特徴とする。
【0008】
請求項3に係る電位治療装置は、約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ前記周波数の任意の波形で出力して白血球分画の顆粒球とリンパ球との比率を調整する調整手段を備える。
【0009】
請求項4に係る電位治療装置において、調整手段は、電圧変換回路と、振幅・周波数可変回路と、増幅・変調回路(インバータ回路)と、復調回路とを備えることを特徴とする。
【0010】
請求項5に係る白血球分画の顆粒球とリンパ球との比率を調整する方法は、約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ周波数出力波形を正弦波交流波形、+側正弦波交流波形、−側正弦波交流波形、正弦波変調波形、正弦波変調波形に直流成分を加えた重畳波形、ゆらぎ変調波形又は矩形波波形のいずれか1つの波形で出力してなる。
【0011】
【発明の実施の形態】
以下、本発明の一実施例を添付図面を参照して詳述する。
図1、図2及び図3は、それぞれ椅子型、布団型そして座布団型の電位治療装置の概略図を示す。図1において、符号1は、制御装置で、制御装置は商用電源に接続される。そして出力端子は高圧コード2を通して椅子4の座席に設けられている通電シート6に接続される。椅子に座った人の足が載せられる絶縁台8が、設けられている。図2において、椅子の代わりに布団10が使用される。布団の上に通電パット11が、人の腰部付近に置かれ、対電極12は、枕の下、又は枕の中に置かれる。絶縁体はベッドの脚部に設置され、床面に接している。図3において、椅子、布団に代わり座布団13が使用される。座布団は、畳や床上に絶縁シート14上に置かれる。座布団上に通電パット15が置かれる。
【0012】
電位治療装置は、商用電源100ボルトの電圧を制御装置に組み込まれた電圧変換回路(トランス)によって所定の電圧に変換し、インバータ回路、安全回路(高いインピーダンス素子)、変調回路等を備えた電源回路を通して出力端子に導く。出力端子の一端は大地に接続され、他端は大地より絶縁された電極に接続され、その電極から人体に高電位を負荷させる。周波数は、約30kHzから約50kHz、出力電圧は、約500ボルトから約5000ボルト、電流は、約1.0mAから約0.005mAである。
【0013】
ここで、電源回路のブロック図は、図4に示されている。図4の電源回路は、周波数可変及び振幅可変回路、インバータ回路及び復調回路を備える。この電源回路から出力される出力波形は、正弦波交流波形、+側正弦波交流波形、−側正弦波交流波形、正弦波変調波形、正弦波変調波形に直流成分を加えた重畳波形、ゆらぎ変調波形又は矩形波波形のいずれか1つである。そして、この電源回路は、周波数の任意の波形で出力して白血球分画の顆粒球とリンパ球との比率を調整する調整手段を構成する。
【0014】
図4において、100V、50〜60Hz用商用電源から出力は、電源回路に入力する。電源回路の出力は、電源回路16を介して、振幅・周波数可変回路17に入力される。振幅・周波数可変回路17は、ボリューム18と、可変インダクタ19を備える。入力信号の振幅の大きさは、ボリューム18により可変され、一方、周波数は、可変インダクタ19の可変により可変される。増幅・変調回路(インバータ回路)20は、プッシュプル発振回路22と、このプッシュプル発振回路により電圧を昇圧し、及び該電位を高周波で変調するための高周波トランス24を備える。かくして、出力波形の振幅は、可変インダクタを可変させることで出力波形の周波数を実際の負荷に合わせて自由に調整できる。また、ボリューム及び可変インダクタの機能は自動制御が可能である。なお、増幅・変調回路(インバータ回路)20の出力は、復調回路26に入力される.復調回路26は、ダイオード28、抵抗30及びコンデンサ32を備える。
【0015】
かくして、約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ前記周波数を任意の波形で出力することにより、白血球分画の顆粒球とリンパ球との比率を調整し、白血球分画の顆粒球は減少してリンパ球が増加する。顆粒球の減少は、交感神経の緊張を抑えて活性酸素を減らす。一方、リンパ球の増加は、副交感神経を優位にして血液を回復させて免疫力を高める。
【0016】
【実施例】
当社の電位治療器である「ビバックス」(商標名)を使用して白血球分画の顆粒球とリンパ球との比率を調整する実験を行った。実験に際して、上述した図2に示すベッド台に人を寝かせて行った。このベッド台は、絶縁ゴムを取り付けた4本の脚部に水平板を置き、この上にマットを介して布団を敷いてある。布団の上面で横に寝た人の腰付近に電極板を置き、一方布団の下側にアース電極を置いた。そして、電極板に制御装置から高圧電圧を加え、アース電極は床でアースを取り、出力電圧を950ボルト、電流を1.0mA、出力周波数を約38.5kHzの+側正弦波交流を使用した。ここで、サンプル数(白血球分画の顆粒球とリンパ球との比率に何らかの問題がある人);32人に以下に述べる電位治療器である「ビバックス」(商標名)を使用による白血球分画の顆粒球とリンパ球との比率の改善が認められた。
【0017】
試験方法は、以下にして行った。まず、本人に通電を知覚されないようにして安静状態で仰向位に寝かせて血液を2cc採血し、かつ脈拍を測定した(ブラインドテストによる)。そして人に電位治療器を使用して15分間上記条件で電位をかけた。その後、15分後に再度血液を採血した。
【0018】
電位治療器で電位をかける前で、顆粒球が多く、リンパ球の少ない人、また脈拍数の多いサンプル数;32のそれぞれについて、その前後で白血球分画の顆粒球とリンパ球の割合、脈拍数の変化を調べた。その結果を図5及び図6に示す。図5は、顆粒球とリンパ球の割合変化を示す。図6は、脈拍数の変化を示す。図5に示すように、電位をかける前と後において、顆粒球は、約64%から約60%に減少し、一方リンパ球は、約31%から約35%に増加していることがわかる。ここで一般に、顆粒球とリンパ球との比率において、顆粒球の正常値は、約54〜約60%、リンパ球の正常値は、約35%〜約41%である。従って、顆粒球とリンパ球の割合は正常値の範囲内に入ってきていることがわかる。また、図6に示すように、脈拍数において、その前後で約70から約65減少していることがわかる。脈拍の正常値は、約65である。かくして、顆粒球が多く、リンパ球の少ない人は、正常値に近づき、また脈拍数の高い人も正常値に近づいている。
【0019】
顆粒数が増えると交感神経が優位になり、心臓の拍動が増えて血管が収縮して血圧が上昇する。電位治療器で電位をかけることにより顆粒球が減少してリンパ球が増えることにより、副交感神経が優位になり心臓の拍動が抑えられ血管が拡張して血液循環が良くなり血圧が抑えられて心身は休息モードに入る。
【0020】
また、過労等心身のストレスがあると、交感神経と副交換神経のバランスが乱れやすくなり、これに連動して顆粒球とリンパ球のバランスも乱れるようになる。ストレスは交感神経を緊張させ顆粒球を増やす。かくして、電位治療器で電位をかけることにより顆粒球が減少してリンパ球が増えることにより、副交感神経が優位になりストレスが緩和される。
【0021】
このように電位治療器で電位をかけることにより交感神経を抑え、副交感神経を優位にする作用がある。その結果、リンパ球が増え、血流がよくなって免疫力が高まる。
【0022】
【発明の効果】
本発明に係る白血球分画の顆粒球とリンパ球との比率を調整する方法及電位治療装置によれば、患者は椅子に座り、布団に寝、あるいは座布団に座わり、電位治療装置を作動させるだけの簡単に、患者に何の苦痛を与えることなしに交感神経を抑え、副交感神経を優位にする作用が得られる。その結果、リンパ球が増え、血流がよくなって免疫力が高まり、血圧を下げ、あるいは疲労を回復させる効用が得られる。
【図面の簡単な説明】
【図1】図1は、椅子型の電位治療装置を示す概略図である。
【図2】図2は、布団型の電位治療装置を示す概略図である。
【図3】図2は、座布団型の電位治療装置を示す概略図である。
【図4】図4は、電源回路を示すブロック図である。
【図5】図5は、電位治療を行う前後での顆粒球とリンパ球の割合の変化を示す図である。
【図6】図6は、電位治療を行う前後での脈拍数の変化を示す図である。
【符号の説明】
1;制御装置
2;高圧コード
4;椅子
6;通電シート
8;絶縁台
10;布団
11、12;絶縁シート
13;座布団
14;絶縁シート
15;通電パット
12;電源回路
18;ボリューム
19;可変インダクタ
20;増幅・変調回路(インバータ回路)
22;プッシュプル発振回路
26;復調回路
[0001]
[Industrial applications]
The present invention relates to a method for controlling a potential therapy apparatus, a potential therapy apparatus, a method for adjusting the ratio of granulocytes to lymphocytes in a leukocyte fraction, and a potential therapy apparatus for adjusting the function of the autonomic nerve.
[0002]
[Prior art]
One cubic millimeter of human blood contains 500 red blood cells and 5000 to 8000 white blood cells. Also, 54 to 60% of the leukocyte fraction is granulocytes, and 35 to 41% are lymphocytes. It is known that the balance between the autonomic nerves, that is, the sympathetic nerve and the parasympathetic nerve, tends to be disturbed when there is anxiety or overworked mental and physical stress, and the balance between granulocytes and lymphocytes is also disturbed in conjunction with this. I have.
[0003]
Thus, when the sympathetic nervous system becomes dominant, granulocytes increase, and the pulsation of the heart increases, the blood vessels contract, the blood pressure increases, and the mind and body enter the active mode. When the parasympathetic nerve becomes dominant, the number of lymphocytes increases, the pulsation of the heart is suppressed, the blood vessels expand and blood circulation improves, the blood pressure decreases, the number of lymphocytes increases, and the mind and body enter a resting mode.
[0004]
As a physical prescription in Oriental medicine for controlling the ratio of granulocytes and lymphocytes linked to these sympathetic nerves and parasympathetic nerves, there is known a method of inserting a needle into a predetermined acupoint and energizing the needle. In this prescription, a specialized doctor examines the position of the acupoint and energizes. Therefore, the patient must go to a hospital or the like for treatment each time by a specialized doctor. For this reason, there were time constraints and inconvenience for the patient.
[0005]
Technical Problem to be Solved by the Invention
The present invention has been made in view of solving such a conventional problem, and an object of the present invention is to adjust the autonomic nervous system easily at home without the need for a patient to see a doctor each time. It is an object of the present invention to provide a method for controlling a potential therapy device, a potential therapy device, and a method for adjusting the ratio of granulocytes to lymphocytes in a leukocyte fraction.
[0006]
[Means for achieving the technical task]
The electric potential therapy apparatus control method according to claim 1, wherein a frequency of about 30 kHz to about 50 kHz, a voltage of about 500 volts to about 5000 volts is applied to the human body to flow a weak current, and the frequency output waveform is a sine wave AC waveform, Sine wave AC waveform,-side sine wave AC waveform, sine wave modulation waveform, superimposed waveform obtained by adding DC component to sine wave modulation waveform, fluctuation modulation waveform or rectangular wave waveform, and output as any one of white blood cell fractionation Adjust the ratio of granulocytes to lymphocytes.
[0007]
According to a second aspect of the present invention, there is provided a method for controlling a potential therapy apparatus, wherein the number of granulocytes in the leukocyte fraction is decreased and the number of lymphocytes is increased.
[0008]
The potential therapy device according to claim 3, wherein a weak current is applied by applying a frequency of about 30 kHz to about 50 kHz and a voltage of about 500 volts to about 5000 volts to a human body, and is output with an arbitrary waveform of the frequency to separate leukocytes. Adjusting means for adjusting the ratio of granulocytes to lymphocytes.
[0009]
According to a fourth aspect of the present invention, in the potential therapy apparatus, the adjusting means includes a voltage conversion circuit, an amplitude / frequency variable circuit, an amplification / modulation circuit (an inverter circuit), and a demodulation circuit.
[0010]
The method of adjusting the ratio of granulocytes and lymphocytes in the leukocyte fraction according to claim 5, comprises applying a weak current by applying a frequency of about 30 kHz to about 50 kHz, about 500 volts to about 5000 volts to the human body, and The frequency output waveform is any of a sine wave AC waveform, a + side sine wave AC waveform, a − side sine wave AC waveform, a sine wave modulation waveform, a superimposed waveform obtained by adding a DC component to a sine wave modulation waveform, a fluctuation modulation waveform, or a square wave waveform. It is output in one waveform.
[0011]
BEST MODE FOR CARRYING OUT THE INVENTION
Hereinafter, an embodiment of the present invention will be described in detail with reference to the accompanying drawings.
FIGS. 1, 2 and 3 show schematic views of chair type, futon type and cushion type potential therapy devices, respectively. In FIG. 1, reference numeral 1 denotes a control device, which is connected to a commercial power supply. The output terminal is connected through a high-voltage cord 2 to a current-carrying seat 6 provided on a seat of a chair 4. An insulating stand 8 is provided on which the feet of the person sitting on the chair are placed. In FIG. 2, a futon 10 is used instead of a chair. An energizing pad 11 is placed on the futon near the waist of the person, and the counter electrode 12 is placed under or in the pillow. Insulation is placed on the bed legs and in contact with the floor. In FIG. 3, a cushion 13 is used instead of a chair and a futon. The cushion is placed on the insulating sheet 14 on a tatami or floor. The energizing pad 15 is placed on the cushion.
[0012]
The electric potential therapy apparatus converts a voltage of 100 volts of commercial power into a predetermined voltage by a voltage conversion circuit (transformer) incorporated in a control device, and includes a power supply including an inverter circuit, a safety circuit (high impedance element), a modulation circuit, and the like. Guide to the output terminal through the circuit. One end of the output terminal is connected to the ground, and the other end is connected to an electrode insulated from the ground, and applies a high potential to the human body from the electrode. The frequency is about 30 kHz to about 50 kHz, the output voltage is about 500 volts to about 5000 volts, and the current is about 1.0 mA to about 0.005 mA.
[0013]
Here, a block diagram of the power supply circuit is shown in FIG. The power supply circuit of FIG. 4 includes a frequency variable and amplitude variable circuit, an inverter circuit, and a demodulation circuit. The output waveform output from the power supply circuit includes a sine wave AC waveform, a + side sine wave AC waveform, a − side sine wave AC waveform, a sine wave modulation waveform, a superimposed waveform obtained by adding a DC component to the sine wave modulation waveform, and fluctuation modulation. One of a waveform and a rectangular waveform. This power supply circuit constitutes an adjusting means for outputting an arbitrary frequency waveform and adjusting the ratio of granulocytes to lymphocytes in the leukocyte fraction.
[0014]
In FIG. 4, an output from a commercial power supply for 100 V, 50 to 60 Hz is input to a power supply circuit. The output of the power supply circuit is input to the amplitude / frequency variable circuit 17 via the power supply circuit 16. The amplitude / frequency variable circuit 17 includes a volume 18 and a variable inductor 19. The magnitude of the amplitude of the input signal is varied by the volume 18, while the frequency is varied by the variable inductor 19. The amplification / modulation circuit (inverter circuit) 20 includes a push-pull oscillation circuit 22, and a high-frequency transformer 24 for boosting a voltage by the push-pull oscillation circuit and modulating the potential at a high frequency. Thus, the amplitude of the output waveform can be freely adjusted according to the actual load by changing the variable inductor. The functions of the volume and the variable inductor can be automatically controlled. The output of the amplification / modulation circuit (inverter circuit) 20 is input to the demodulation circuit 26. The demodulation circuit 26 includes a diode 28, a resistor 30, and a capacitor 32.
[0015]
Thus, by applying a frequency of about 30 kHz to about 50 kHz, about 500 volts to about 5000 volts to the human body and passing a weak current, and outputting the frequency in an arbitrary waveform, the granulocytes and lymphocytes of the white blood cell fraction By adjusting the ratio, granulocytes in the leukocyte fraction decrease and lymphocytes increase. Granulocyte depletion reduces sympathetic tone and reduces reactive oxygen species. On the other hand, the increase in lymphocytes predominates the parasympathetic nerve and restores blood to enhance immunity.
[0016]
【Example】
An experiment was performed to adjust the ratio of granulocytes to lymphocytes in the leukocyte fraction using "Vivax" (trade name) which is a potential therapy device of our company. During the experiment, a person was laid on the bed shown in FIG. 2 described above. In this bed stand, a horizontal plate is placed on four legs to which insulating rubber is attached, and a futon is laid on the horizontal plate via a mat. An electrode plate was placed near the waist of a person lying on the top of the futon, while an earth electrode was placed below the futon. Then, a high voltage was applied to the electrode plate from the control device, the ground electrode was grounded on the floor, and an output voltage of 950 volts, a current of 1.0 mA, and an output frequency of about 38.5 kHz were used. . Here, the number of samples (for those who have some problem in the ratio of granulocytes to lymphocytes in the leukocyte fraction); 32 leukocyte fractionation using "Vivax" (trade name) which is a potential therapy device described below An improvement in the ratio of granulocytes to lymphocytes was observed.
[0017]
The test method was performed as follows. First, 2cc of blood was collected and the pulse was measured (by a blind test) while the patient was placed in a supine position in a resting state without being perceived to be energized. Then, a potential was applied to the person under the above conditions for 15 minutes using a potential therapy device. Thereafter, blood was collected again 15 minutes later.
[0018]
Before applying an electric potential with a potential therapy device, a person with many granulocytes and few lymphocytes, and a sample with a high pulse rate; for each of 32, the ratio of granulocytes and lymphocytes in the leukocyte fraction before and after, pulse The change in number was examined. The results are shown in FIGS. FIG. 5 shows the change in the ratio between granulocytes and lymphocytes. FIG. 6 shows the change in pulse rate. As shown in FIG. 5, it can be seen that before and after applying the potential, granulocytes decrease from about 64% to about 60%, while lymphocytes increase from about 31% to about 35%. . Generally, in the ratio of granulocytes to lymphocytes, the normal value of granulocytes is about 54 to about 60%, and the normal value of lymphocytes is about 35% to about 41%. Therefore, it can be seen that the ratio of granulocytes and lymphocytes is within the range of normal values. In addition, as shown in FIG. 6, it can be seen that the pulse rate decreases by about 70 to about 65 before and after the pulse rate. The normal value of the pulse is about 65. Thus, those with more granulocytes and less lymphocytes are closer to normal, and those with higher pulse rates are closer to normal.
[0019]
As the number of granules increases, the sympathetic nerve becomes dominant, the heart beats more, the blood vessels contract, and blood pressure rises. By applying an electric potential with a potential therapy device, granulocytes decrease and lymphocytes increase, parasympathetic nerve becomes dominant, heart pulsation is suppressed, blood vessels expand, blood circulation improves, blood pressure is suppressed The mind and body enter the rest mode.
[0020]
In addition, if there is mental or physical stress such as overwork, the balance between the sympathetic nerve and the parasympathetic nerve tends to be disturbed, and the balance between granulocytes and lymphocytes also disturbs in conjunction with this. Stress causes sympathetic tone and increases granulocytes. Thus, by applying an electric potential with the electric potential therapy device, granulocytes decrease and lymphocytes increase, so that parasympathetic nerves become dominant and stress is relieved.
[0021]
The application of a potential by the potential therapy device has the effect of suppressing the sympathetic nerve and giving the parasympathetic nerve superiority. As a result, lymphocytes increase, blood flow improves, and immunity increases.
[0022]
【The invention's effect】
According to the method for controlling the ratio of granulocytes and lymphocytes in the leukocyte fraction and the potential therapy apparatus according to the present invention, a patient sits on a chair, lays on a futon, or sits on a cushion, and activates the potential therapy apparatus. Simply, the effect of suppressing the sympathetic nerve and giving the parasympathetic nerve superiority without causing any pain to the patient can be obtained. As a result, lymphocytes are increased, blood flow is improved, immunity is increased, blood pressure is reduced, and the effect of relieving fatigue is obtained.
[Brief description of the drawings]
FIG. 1 is a schematic view showing a chair-type electric potential therapy apparatus.
FIG. 2 is a schematic view showing a futon-type potential therapy apparatus.
FIG. 2 is a schematic diagram showing a cushion type electric potential therapy apparatus.
FIG. 4 is a block diagram illustrating a power supply circuit.
FIG. 5 is a diagram showing a change in the ratio of granulocytes and lymphocytes before and after performing potential therapy.
FIG. 6 is a diagram showing a change in pulse rate before and after performing a potential treatment.
[Explanation of symbols]
1; control device 2; high-voltage cord 4; chair 6; conducting sheet 8; insulating table 10; futons 11 and 12; insulating sheet 13; cushion 14; insulating sheet 15; 20; amplification / modulation circuit (inverter circuit)
22; push-pull oscillation circuit 26; demodulation circuit

Claims (5)

約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ周波数出力波形を正弦波交流波形、+側正弦波交流波形、−側正弦波交流波形、正弦波変調波形、正弦波変調波形に直流成分を加えた重畳波形、ゆらぎ変調波形又は矩形波波形のいずれか1つの波形で出力して白血球分画の顆粒球とリンパ球との比率を調整する電位治療装置制御方法。A frequency of about 30 kHz to about 50 kHz, a voltage of about 500 volts to about 5000 volts is applied to the human body to flow a weak current, and a frequency output waveform is a sine wave AC waveform, a + side sine wave AC waveform, a − side sine wave AC waveform, A sine wave modulation waveform, a superimposed waveform obtained by adding a DC component to the sine wave modulation waveform, a fluctuation modulation waveform, or a rectangular wave waveform is output as any one of the waveforms to adjust the ratio of granulocytes to lymphocytes in the leukocyte fraction. A method for controlling a potential therapy device. 白血球分画の顆粒球を減少してリンパ球を増やすことを特徴とする請求項1記載の電位治療装置制御方法。2. The method according to claim 1, wherein granulocytes in the leukocyte fraction are reduced to increase lymphocytes. 約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ前記周波数の任意の波形で出力して白血球分画の顆粒球とリンパ球との比率を調整する調整手段を備える電位治療装置。A frequency of about 30 kHz to about 50 kHz, a voltage of about 500 volts to about 5,000 volts is applied to the human body to flow a weak current, and output with an arbitrary waveform of the frequency to obtain a ratio of granulocytes to lymphocytes in a leukocyte fraction. An electric potential therapy device comprising an adjusting means for adjusting. 前記調整手段は、電圧変換回路と、振幅・周波数可変回路と、増幅・変調回路(インバータ回路)と、復調回路とを備えることを特徴とする請求項3に記載の電位治療装置。The electric potential therapy apparatus according to claim 3, wherein the adjustment unit includes a voltage conversion circuit, an amplitude / frequency variable circuit, an amplification / modulation circuit (an inverter circuit), and a demodulation circuit. 約30kHzから約50kHzの周波数、約500ボルトから約5000ボルトを人体に印加して微弱電流を流し、かつ周波数出力波形を正弦波交流波形、+側正弦波交流波形、−側正弦波交流波形、正弦波変調波形、正弦波変調波形に直流成分を加えた重畳波形、ゆらぎ変調波形又は矩形波波形のいずれか1つの波形で出力して白血球分画の顆粒球とリンパ球との比率を調整する方法。A frequency of about 30 kHz to about 50 kHz, a voltage of about 500 volts to about 5000 volts is applied to the human body to flow a weak current, and a frequency output waveform is a sine wave AC waveform, a + side sine wave AC waveform, a − side sine wave AC waveform, A sine wave modulation waveform, a superimposed waveform obtained by adding a DC component to the sine wave modulation waveform, a fluctuation modulation waveform, or a rectangular wave waveform is output as any one of the waveforms to adjust the ratio of granulocytes to lymphocytes in the leukocyte fraction. Method.
JP2003070950A 2003-02-10 2003-02-10 Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction Pending JP2004243048A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003070950A JP2004243048A (en) 2003-02-10 2003-02-10 Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003070950A JP2004243048A (en) 2003-02-10 2003-02-10 Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction

Publications (1)

Publication Number Publication Date
JP2004243048A true JP2004243048A (en) 2004-09-02

Family

ID=33027666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003070950A Pending JP2004243048A (en) 2003-02-10 2003-02-10 Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction

Country Status (1)

Country Link
JP (1) JP2004243048A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006107075A1 (en) * 2005-04-05 2006-10-12 Bestec Corporation Potential application apparatus
JP2006346301A (en) * 2005-06-17 2006-12-28 Marutaka Techno:Kk Potential treatment apparatus
JP2007014623A (en) * 2005-07-08 2007-01-25 Hakuju Inst For Health Science Co Ltd Potential therapy device
US8251941B2 (en) 2007-08-31 2012-08-28 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
WO2014175700A1 (en) * 2013-04-25 2014-10-30 Oh Jaesuk Micro-current therapy device using high electric potential
US10695482B2 (en) 2011-10-14 2020-06-30 Seastar Medical, Inc. Cartridge and method for increasing myocardial function
US11118162B2 (en) 2010-10-15 2021-09-14 Seastar Medical, Inc. Cytopheresis cartridges and use thereof

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006107075A1 (en) * 2005-04-05 2006-10-12 Bestec Corporation Potential application apparatus
JPWO2006107075A1 (en) * 2005-04-05 2008-09-25 株式会社ベステック Potential application device
JP2006346301A (en) * 2005-06-17 2006-12-28 Marutaka Techno:Kk Potential treatment apparatus
JP2007014623A (en) * 2005-07-08 2007-01-25 Hakuju Inst For Health Science Co Ltd Potential therapy device
US8425447B2 (en) 2007-08-31 2013-04-23 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US8409126B2 (en) 2007-08-31 2013-04-02 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US8425445B2 (en) 2007-08-31 2013-04-23 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US8425446B2 (en) 2007-08-31 2013-04-23 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods
US8430832B2 (en) 2007-08-31 2013-04-30 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US9128093B2 (en) 2007-08-31 2015-09-08 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US9341626B2 (en) 2007-08-31 2016-05-17 Cytopherx, Inc. Selective cytopheresis devices and related methods thereof
US9498566B2 (en) 2007-08-31 2016-11-22 Cytopherx, Inc. Selective cytopheresis devices and related methods thereof
US8251941B2 (en) 2007-08-31 2012-08-28 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US11118162B2 (en) 2010-10-15 2021-09-14 Seastar Medical, Inc. Cytopheresis cartridges and use thereof
US12478923B2 (en) 2010-10-15 2025-11-25 Seastar Medical, Inc. Cytopheresis cartridges and use thereof
US11866730B2 (en) 2010-10-15 2024-01-09 Seastar Medical, Inc. Cytopheresis cartridges and use thereof
US10695482B2 (en) 2011-10-14 2020-06-30 Seastar Medical, Inc. Cartridge and method for increasing myocardial function
US10722637B2 (en) 2012-01-09 2020-07-28 Seastar Medical, Inc. Cartridge and method for increasing myocardial function
US11439739B2 (en) 2012-01-09 2022-09-13 Seastar Medical, Inc. Cartridge and method for increasing myocardial function
US9504823B2 (en) 2013-04-25 2016-11-29 Jaesuk OH Micro-current therapy device using high electric potential
WO2014175700A1 (en) * 2013-04-25 2014-10-30 Oh Jaesuk Micro-current therapy device using high electric potential

Similar Documents

Publication Publication Date Title
KR102120386B1 (en) Electric potential treatment device
TW200927207A (en) System for blood-pressure stabilization by transcutaneous electrical stimulation
US20100145399A1 (en) Multifunction devices and methods of using the multifunction devices
CN108261607B (en) A functional transcutaneous electrical nerve stimulation device for motor function regulation
EP0357647B1 (en) Electrostimulating device
JP7048121B2 (en) Electrical stimulator
US20050187591A1 (en) Electro therapy method and apparatus
JP2004243048A (en) Potential therapy device control method, potential therapy device, and method for adjusting ratio of granulocytes to lymphocytes in leukocyte fraction
CN107469232B (en) A kind of electrodeless electro-therapeutic apparatus of intermediate frequency
CN102218194A (en) Modulation type high-voltage electrostatic-field air-negative-ion comprehensive physiotherapy unit
KR102427506B1 (en) Interferential current type low-frequency pulse stimulator
CN201431610Y (en) Multifunctional physiotherapy instrument
KR101169007B1 (en) Low Frequency Therapy Apparatus Using Interferential Wave Current
KR101668989B1 (en) Medical multi stimulator
RU2496533C2 (en) Magnetic therapy apparatus
JP2004243047A (en) Potential therapy system, electronic medium and information writing device
RU2264234C1 (en) Method for craniospinal electromagnet therapy and device for its realization
CN213553352U (en) Household intermediate frequency interference physiotherapy instrument circuit
CN212593519U (en) Magnetic therapeutic apparatus with magnetic line of force emitter
CN207429326U (en) A kind of new combination of Chinese tradiational and Western medicine diagnosis and treatment bed
CN218899263U (en) Pulse massage bathtub
JP2895279B2 (en) Low frequency electric therapy equipment
CN110478619A (en) A kind of magnetic line of force emitter and the magnet therapeutic apparatus with magnetic line of force emitter
JP2013188241A (en) Apparatus for treating brain fatigue and/or depression, and method of use thereof
JPH0659313B2 (en) EEG frequency reduction induction device